Page last updated: 2024-08-18

acrylonitrile and Myeloproliferative Disorders

acrylonitrile has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blum, MC; Breitenbuecher, F; Fischer, T; Heidel, F; Hoffmann, LS; Huber, C; Kasper, S; Kindler, T; Levine, RL; Lipka, DB; Markova, B	1

Other Studies

1 other study(ies) available for acrylonitrile and Myeloproliferative Disorders

Article	Year
LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells. Molecular cancer therapeutics, 2008, Volume: 7, Issue:5 Topics: Acrylonitrile; Adenosine Triphosphate; Animals; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Janus Kinase 2; K562 Cells; Mice; Myeloproliferative Disorders; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Styrenes	2008

Article

Year

LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells.

Molecular cancer therapeutics, 2008, Volume: 7, Issue:5

Topics: Acrylonitrile; Adenosine Triphosphate; Animals; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Janus Kinase 2; K562 Cells; Mice; Myeloproliferative Disorders; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; Styrenes

2008